1. Home
  2. XGN vs FENG Comparison

XGN vs FENG Comparison

Compare XGN & FENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XGN
  • FENG
  • Stock Information
  • Founded
  • XGN 2002
  • FENG 1998
  • Country
  • XGN United States
  • FENG China
  • Employees
  • XGN N/A
  • FENG N/A
  • Industry
  • XGN Medical Specialities
  • FENG Broadcasting
  • Sector
  • XGN Health Care
  • FENG Industrials
  • Exchange
  • XGN Nasdaq
  • FENG Nasdaq
  • Market Cap
  • XGN 138.3M
  • FENG N/A
  • IPO Year
  • XGN 2019
  • FENG 2011
  • Fundamental
  • Price
  • XGN $7.05
  • FENG N/A
  • Analyst Decision
  • XGN Strong Buy
  • FENG
  • Analyst Count
  • XGN 2
  • FENG 0
  • Target Price
  • XGN $7.50
  • FENG N/A
  • AVG Volume (30 Days)
  • XGN 232.0K
  • FENG 6.9K
  • Earning Date
  • XGN 08-04-2025
  • FENG 08-12-2025
  • Dividend Yield
  • XGN N/A
  • FENG N/A
  • EPS Growth
  • XGN N/A
  • FENG N/A
  • EPS
  • XGN N/A
  • FENG N/A
  • Revenue
  • XGN $56,724,000.00
  • FENG $97,280,369.00
  • Revenue This Year
  • XGN $19.39
  • FENG N/A
  • Revenue Next Year
  • XGN $13.27
  • FENG N/A
  • P/E Ratio
  • XGN N/A
  • FENG N/A
  • Revenue Growth
  • XGN 1.78
  • FENG 1.04
  • 52 Week Low
  • XGN $1.71
  • FENG $1.28
  • 52 Week High
  • XGN $7.95
  • FENG $4.15
  • Technical
  • Relative Strength Index (RSI)
  • XGN 53.33
  • FENG 52.09
  • Support Level
  • XGN $6.68
  • FENG $2.01
  • Resistance Level
  • XGN $7.38
  • FENG $2.38
  • Average True Range (ATR)
  • XGN 0.45
  • FENG 0.15
  • MACD
  • XGN -0.08
  • FENG 0.02
  • Stochastic Oscillator
  • XGN 32.33
  • FENG 44.74

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Share on Social Networks: